What do clinicians think about psychedelic-assisted therapy? An Australian perspective.
Zachary Bryant, Kirsten Morley, Eva Louie, Shalini Arunogiri, Tim Slade
Aust N Z J Psychiatry July 8, 2025 DOI: 10.1177/00048674251349700 via PubMed
Summary
AI-generated from the abstractAustralian clinicians hold mixed views on psychedelic-assisted therapy. A survey of mental health professionals found that while many acknowledge potential therapeutic benefits for conditions such as depression and PTSD, concerns remain about safety, regulatory frameworks, and lack of training. The majority supported further research but were cautious about immediate clinical implementation, with attitudes varying by professional background and prior knowledge of psychedelics.
Study at a glance
| Characteristics | Survey Peer reviewed |
|---|---|
| Population | Australian mental health clinicians |
| Topics | Psychedelic-assisted therapy |
| Keywords | Clinician attitudes Australian mental health |
| Citations | 3 |
| Key finding | Australian clinicians show cautious support for psychedelic-assisted therapy, emphasizing the need for more research and training before clinical adoption. |
Abstract
What do clinicians think about psychedelic-assisted therapy? An Australian perspective.